RLD2102
Sponsors
Hanmi Pharmaceutical Company Limited
Conditions
Healthy
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers
CompletedNCT05155995
Start: 2021-09-28End: 2022-11-27Updated: 2023-09-22
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers
CompletedNCT06346184
Start: 2024-05-02End: 2024-06-10Updated: 2024-07-16
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
CompletedNCT06357910
Start: 2024-05-17End: 2024-07-01Updated: 2024-07-16
A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers
CompletedNCT06518122
Start: 2024-09-01End: 2025-01-03Updated: 2025-02-20